Maravai Lifesciences Holdings (MRVI) Depreciation & Amortization (CF) (2020 - 2026)

Maravai Lifesciences Holdings' Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• In Q1 2026, Depreciation & Amortization (CF) fell 13.93% year-over-year to $4.9 million; the TTM figure through Mar 2026 stood at $22.8 million (up 4.59% YoY), while the FY2025 annual figure was $23.6 million, up 12.92% from the prior year.
• Depreciation & Amortization (CF) was $4.9 million for Q1 2026 at Maravai Lifesciences Holdings, down from $6.0 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $6.0 million in Q3 2025 to a low of $1.9 million in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $4.1 million across 5 years, with a median of $4.8 million in 2024.
• The sharpest annual moves came in 2024 and 2026: Depreciation & Amortization (CF) surged 130.1% in 2024, then retreated 13.93% in 2026.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.0 million in 2022, then surged by 100.41% to $3.9 million in 2023, then jumped by 40.23% to $5.5 million in 2024, then grew by 8.36% to $6.0 million in 2025, then fell by 17.99% to $4.9 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $4.9 million (Q1 2026), $6.0 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.